NRP1 and Hypoglycemia: In conclusion, this data shows that strict blood glucose control associated with increased hypoglycemia potentiates sNRP1 levels via a mechanism involving ADAM9-mediated proteolytic cleavage of NRP1 that may continue to enhance sNRP1 levels following the hypoglycemic episode, independent of RAS activation or ACEi therapy.